NASDAQ:SYRS - Syros Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$9.22 -0.37 (-3.86 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$9.22
Today's Range$9.21 - $9.6217
52-Week Range$5.17 - $13.86
Volume147,149 shs
Average Volume154,901 shs
Market Capitalization$302.14 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22

SEC Filings

Syros Pharmaceuticals (NASDAQ:SYRS) SEC Filings

DateFilerForm TypeView
03/14/2019
5:57 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/11/2019
4:58 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
8:18 AM
Syros Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/07/2019
5:32 AM
Syros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
2:07 PM
ARCH Venture Fund VII, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2019
10:32 AM
ARK Investment Management LLC (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G
View Filing
02/14/2019
5:28 AM
Polaris Partners VII, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
01/11/2019
4:02 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
5:30 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/03/2018
7:07 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/19/2018
10:50 AM
Syros Pharmaceuticals (Filer)
Form CT ORDER
View Filing
11/15/2018
3:03 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/01/2018
5:25 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
09/26/2018
7:31 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/24/2018
4:01 PM
Syros Pharmaceuticals (Filer)
Form 10-Q/A
View Filing
08/24/2018
4:01 PM
Syros Pharmaceuticals (Filer)
Form 10-Q/A
View Filing
08/24/2018
4:00 PM
Syros Pharmaceuticals (Filer)
Form 10-K/A
View Filing
08/07/2018
5:57 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
06/15/2018
3:30 PM
Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:30 PM
Syros Pharmaceuticals (Issuer)
WIRTH PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:29 PM
SHARP PHILIP A (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:29 PM
SATO VICKI L (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:29 PM
Nashat Amir (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:28 PM
Fanucci Marsha (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:28 PM
BONNEY MICHAEL W (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
3:24 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
7:51 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2018
5:49 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/26/2018
6:04 AM
Syros Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/26/2018
6:03 AM
Syros Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/15/2018
6:55 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
4:10 PM
Ferra Joseph J Jr (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2018
4:09 PM
Ferra Joseph J Jr (Reporting)
Syros Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/12/2018
6:44 AM
Syros Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/12/2018
6:30 AM
Syros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
6:05 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/21/2018
3:09 PM
Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/21/2018
3:08 PM
Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/21/2018
3:08 PM
Olson Eric R (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/21/2018
3:08 PM
Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2018
7:52 AM
Flynn James E (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/13/2018
5:43 PM
AFEYAN NOUBAR (Reporting)
Syros Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
11:15 PM
Syros Pharmaceuticals (Filer)
Form EFFECT
View Filing
02/09/2018
7:52 AM
Syros Pharmaceuticals (Filer)
Form D/A
View Filing
02/02/2018
3:29 PM
Arch Venture Fund VII LP (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/02/2018
3:14 PM
Syros Pharmaceuticals (Filer)
Form S-3/A
View Filing
02/02/2018
3:05 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/02/2018
2:53 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/31/2018
8:24 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/30/2018
3:32 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/30/2018
3:30 PM
Syros Pharmaceuticals (Filer)
Form 424B5
View Filing
01/19/2018
4:14 PM
Syros Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
01/17/2018
3:13 PM
Syros Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
View Filing
01/12/2018
4:15 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/08/2018
7:15 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/22/2017
6:30 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 3/A
View Filing
12/15/2017
3:02 PM
Springhorn Jeremy P. (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
7:22 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/11/2017
5:04 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What is Compound Interest?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel